Dongkuk Life Science (CEO Park Jae-won) announced on the 30th that it has signed a sales contract for ultra-low-dose CT AI software with ClariPi, an AI medical imaging company, following the exhibition of cutting-edge AI S/W that diagnoses chest disease and breast cancer.